Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Wajeeh Khan

Nvidia Is Fast Approaching Its 20-Day Moving Average. Is a Comeback Brewing?

Nvidia (NVDA) shares closed in the green on March 31 amid a broader tech-led market rally following reports that Iran is open to ending the war, provided it receives reparations and security guarantees. 

The artificial intelligence (AI) darling is now hovering around its 20-day moving average (MA), with a decisive break above the $178 level expected to boost upward momentum in the near term.

 

Versus its year-to-date high, Nvidia stock is still down more than 10%

www.barchart.com

What Else Helped Nvidia Stock Rally on Tuesday?

Adding to the momentum on Tuesday was Nvidia’s $2 billion investment in Marvell (MRVL)

This was part of its broader $18 billion strategic deployment over the past six months, with similar commitments made to Lumentum (LITE), Coherent (COHR), CoreWeave (CRWV), Synopsys (SNPS), Nebius (NBIS), Nokia (NOK), and others. 

These investments are bullish for NVDA shares, as they’re designed to create a deeply integrated AI ecosystem centered on the firm’s architecture, particularly the “NVLink Fusion” platform and silicon photonics technology. 

By locking partners into its infrastructure stack, Nvidia is building a competitive moat that extends well beyond GPU dominance into networking, custom accelerators, and telecom infrastructure. 

How High Could NVDA Shares Fly in 2026?

Goldman Sachs continues to see massive further upside in Nvidia shares to $250 as the chipmaker cements its role as the foundational computing platform for life sciences. 

In her research note, analyst Salveen Richter said NVDA is no longer just a hardware provider but a strategic partner leveraging agentic AI and digital twins to revolutionize drug discovery and lab automation. 

Through high-profile collaborations, Nvidia is enabling biotech firms to enter clinical trials 60% faster while synthesizing 90% fewer compounds, she added. 

All in all, by optimizing patient recruitment and medicine design via simulation, it’s monetizing the healthcare sector’s urgent push into AI-integrated research and development.

Wall Street Remains Bullish on Nvidia

Other Wall Street analysts agree with Richter on Nvidia, especially since its relative strength index (RSI) remains miles below overbought territory. 

The consensus rating on NVDA stock sits at a “Strong Buy” currently, with the mean price target of an even higher $269, indicating potential upside of about 55% from here. 

www.barchart.com
Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.